Research On Mixed Ownership Reform And Enterprise Mergers And Acquisitions Of Sinopharm Group

Merger and reorganization is one of the ways of mixed ownership reform of state-owned enterprises.With the reform of mixed ownership of state-owned enterprises in China entering a deepening and accelerating period,more and more state-owned enterprises through mergers and acquisitions to complete part of the process of withdrawal and re-entry,to achieve the compatibility of state ownership and market economy.Sinopharm,as the largest pharmaceutical and health industry group directly managed by SASAC,has invested in private enterprises through mergers and acquisitions.After completing the mergers and acquisitions of Insky Pharmaceutical,Tongjitang,Tianjiang Pharmaceutical and other private pharmaceutical enterprises,sinopharm has achieved positive results,improved the industrial chain,and promoted the quality and efficiency of the pharmaceutical industry.Based on the theories of mixed ownership reform and enterprise merger and acquisition,this paper studies the merger and acquisition of state-owned enterprises under the context of mixed ownership reform,based on the case of Sinopagine Group TCM sector.The first part of this article elaborates the research background,significance and mentality,the second part introduces the mixed ownership reform and merger and acquisition of relevant theoretical basis,in the third part analyses the change situation of private enterprises and state-owned enterprises m&a risk points,the fourth part analyze the case of mixed ownership reform,its group,The fifth part analyzes a series of M&A activities of Sinopharm group according to the logic of M&A motivation,M&A process and M&A effect.Finally,the sixth part puts forward research conclusions and suggestions based on the above analysis.Studies have found that its group in mixed change situation of mergers and acquisitions,uphold the original vision,when choosing private enterprises adopt accurate m&a strategy,choose flexible financing,and create integration of advanced concepts.The above factors drive the national medicine group mix to the success of mergers and acquisitions,and promote it to be "stronger,better and bigger" in the pharmaceutical industry.